Article
Novel HIV-1 therapeutics through targeting altered host cell pathways
7 Sept 2009
Abstract excerpt
The emergence of drug-resistant HIV-1 strains presents a challenge for the design of new drugs. Anti-HIV compounds currently in use are the subject of advanced clinical trials using either HIV-1 reverse transcriptase, viral protease or integrase inhibitors. Recent studies show an increase in the number of HIV-1 variants resistant to anti-retroviral agents in newly infected individuals. Targeting host cell factors...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
